Giltiay, Natalia

The adaptor Act1 is required for interleukin 17-dependent signaling associated with autoimmune and inflammatory disease

Qian, Y., Liu, C., Hartupee, J., Altuntas, C. Z., Gulen, M. F., Jane-wit, D., Xiao, J., Lu, Y., Giltiay, N., Liu, J., et al. (2007) · Nature Immunology

Psoriasis: Treatment and PathogenesisNF-κB Signaling Pathways

Cited by 614

Astrocyte-restricted ablation of interleukin-17-induced ACT1-mediated signaling ameliorates autoimmune encephalomyelitis

Kang, Z., Altuntas, C. Z., Gulen, M. F., Liu, C., Giltiay, N., Qin, H., Liu, L., Qian, W., Ransohoff, R. M., Bergmann, C., et al. (2010) · Immunity

Multiple Sclerosis Research StudiesPsoriasis: Treatment and Pathogenesis

Cited by 297

Act1, a U-box E3 Ubiquitin Ligase for IL-17 Signaling

Liu, C., Qian, W., Qian, Y., Giltiay, N. V., Lu, Y., Swaidani, S., Misra, S., Deng, L., Chen, Z. J., & Li, X. (2009) · Science Signaling

NF-κB Signaling PathwaysPsoriasis: Treatment and Pathogenesis

Cited by 224

CD22: A Regulator of Innate and Adaptive B Cell Responses and Autoimmunity

Clark, E. A., & Giltiay, N. V. (2018) · Frontiers in Immunology

T-cell and B-cell ImmunologyGlycosylation and Glycoproteins Research

Cited by 197